Concepedia

Publication | Open Access

ONC201 (Dordaviprone) in Recurrent H3 K27M–Mutant Diffuse Midline Glioma

DOIFull Paper Access

68

Citations

32

References

2024

Year

Isabel Arrillaga‐Romany, Sharon L. Gardner, Yazmín Odia, Dolly Aguilera, Joshua E. Allen, Tracy T. Batchelor, Nicholas Butowski, Clark C. Chen, Timothy F. Cloughesy, Andrew Cluster,
Journal of Clinical Oncology

Abstract

ONC201 monotherapy was well tolerated and exhibited durable and clinically meaningful efficacy in recurrent H3 K27M-mutant DMG.

References

YearCitations

Page 1